These data indicate that the coexpression of FLT3LG and both CCL5 and CCR5 is a simplified biomarker for cDC1 tumor score and overall survival in several types of human cancers with similar or even improved predictive power than whole cDC1 signatures. Here, FLT3LG is linked to cancer.